# Association Between Postoperative Administration of L-Arginine and CSA-AKI

> **NCT06248359** · — · RECRUITING · sponsor: **Xijing Hospital** · enrollment: 7000 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** L-Arginine hydrochloride

## Key facts

- **NCT ID:** NCT06248359
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 7000 (ESTIMATED)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06248359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06248359, "Association Between Postoperative Administration of L-Arginine and CSA-AKI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06248359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*